Anticorps Recombinant de lapin anti-SLC7A11/xCT

SLC7A11/xCT Recombinant Antibody for IF/ICC, FC (Intra), Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IF/ICC, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

230227C5

N° de cat : 82115-2-PBS

Synonymes

SLC7A11, xCT, 230227C5, Amino acid transport system xc, Amino acid transport system xc-



Informations sur le produit

82115-2-PBS cible SLC7A11/xCT dans les applications de IF/ICC, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène SLC7A11/xCT Protéine recombinante Ag25431
Nom complet solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
Masse moléculaire calculée 55 kDa
Numéro d’acquisition GenBankBC012087
Symbole du gène SLC7A11
Identification du gène (NCBI) 23657
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.

{{ptg:RelatedPrimaryAntibodies}}